Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome ; volume:14 ; number:1 ; day:4 ; month:10 ; year:2016 ; pages:159-163 ; date:10.2016
Thrombosis journal ; 14, Heft 1 (4.10.2016), 159-163, 10.2016
- Creator
-
El-Assaad, Fatima
- Contributor
-
Krilis, Steven A.
Giannakopoulos, Bill
SpringerLink (Online service)
- DOI
-
10.1186/s12959-016-0115-z
- URN
-
urn:nbn:de:1111-201610303818
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- El-Assaad, Fatima
- Krilis, Steven A.
- Giannakopoulos, Bill
- SpringerLink (Online service)
Other Objects (12)
Impact of beta2-Glycoprotein I Post-translational Modifications on Protein Conformational Dynamics and Immunogenicity in the Context of the Antiphospholipid Syndrome
Post-translational modification in the pathogenesis of vitiligo
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
Co- and posttranslational engineering of the therapeutic glycoprotein erythropoietin with unnatural amino acids
Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome
![Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
The mTOR pathway in the antiphospholipid syndrome
Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
Novel insights into the roles of glycoprotein B and pUS3 during equine herpesvirus pathogenesis
Impact of beta2-Glycoprotein I Post-translational Modifications on Protein Conformational Dynamics and Immunogenicity in the Context of the Antiphospholipid Syndrome
Post-translational modification in the pathogenesis of vitiligo
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
Co- and posttranslational engineering of the therapeutic glycoprotein erythropoietin with unnatural amino acids
Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome
Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
The mTOR pathway in the antiphospholipid syndrome
Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
Novel insights into the roles of glycoprotein B and pUS3 during equine herpesvirus pathogenesis
Impact of beta2-Glycoprotein I Post-translational Modifications on Protein Conformational Dynamics and Immunogenicity in the Context of the Antiphospholipid Syndrome
Post-translational modification in the pathogenesis of vitiligo
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
Co- and posttranslational engineering of the therapeutic glycoprotein erythropoietin with unnatural amino acids
Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome
Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
The mTOR pathway in the antiphospholipid syndrome
Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus